Regulation of transcription factor activity by interconnected post-translational modifications
Open accessAbstract
Transcription factors comprise just over 7% of the human proteome and serve as gatekeepers of cellular function, integrating external signal information into gene expression programs that reconfigure cellular physiology at the most basic levels. Surface-initiated cell signaling pathways converge on transcription factors, decorating these proteins with an array of post-translational modifications (PTMs) that are often interdependent, being linked in time, space, and combinatorial function. These PTMs orchestrate every activity of a transcription factor over its entire lifespan--from subcellular localization to protein-protein interactions, sequence-specific DNA binding, transcriptional regulatory activity, and protein stability--and play key roles in the epigenetic regulation of gene expression. The multitude of PTMs of transcription factors also offers numerous potential points of intervention for development of therapeutic agents to treat a wide spectrum of diseases. We review PTMs most commonly targeting transcription factors, focusing on recent reports of sequential and linked PTMs of individual factors.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Inhibition of HIF-α hydroxylation can be achieved using PHD inhibitors, including Roxadustat, which is approved in China and Europe for the treatment of renal anemia in CKD, and daprodustat, vadadustat, enarodustat and molidustat, which have been approved in Japan.
“As such, inhibition of HIF-α hydroxylation can be achieved using PHD inhibitors, such as Roxadustat, which is approved in China and Europe for the treatment of renal anemia in CKD, and other PHD inhibitors, daprodustat, vadadustat, enarodustat and molidustat, which have been approved in Japan.637–642”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [637]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Retraction Note: Regulation of MBD1‐mediated transcriptional repression by SUMO and PIAS proteins
Lyst, M. J., Nan, X., & Stancheva, I. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601404 · Cited by 62 · see citing works
RetractedAkt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 6,535 · see citing works
Transcriptional regulation by calcium, calcineurin, and NFAT
Hogan, P. G., Chen, L., Nardone, J., & Rao, A. (2003) · Genes & Development · doi:10.1101/gad.1102703 · Cited by 1,991 · see citing works
Concepts in sumoylation: a decade on
Geiss‐Friedlander, R., & Melchior, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2293 · Cited by 1,788 · see citing works
Hornbeck, P. V., Kornhauser, J. M., Tkachev, S., Zhang, B., Skrzypek, E., Murray, B. W., Latham, V. M., & Sullivan, M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1122 · Cited by 1,636 · see citing works
Métivier, R., Penot, G., Hübner, M. R., Reid, G., Brand, H., Koš, M., & Gannon, F. (2003) · Cell · doi:10.1016/s0092-8674(03)00934-6 · Cited by 1,431 · see citing works
Mammalian SIRT1 Represses Forkhead Transcription Factors
Motta, M. C., Divecha, N., Lemieux, M. E., Kamel, C., Chen, D., Gu, W. J., Bultsma, Y., McBurney, M. W., & Guarente, L. (2004) · Cell · doi:10.1016/s0092-8674(04)00126-6 · Cited by 1,351 · see citing works
Hart, G. W., Slawson, C., Ramirez-Correa, G., & Lagerlof, O. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060608-102511 · Cited by 1,317 · see citing works
Biggs, W., Meisenhelder, J., Hunter, T. R., Cavenee, W. K., & Arden, K. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7421 · Cited by 1,116 · see citing works
TRANSCRIPTIONAL CONTROL OF MUSCLE DEVELOPMENT BY MYOCYTE ENHANCER FACTOR-2 (MEF2) PROTEINS
Black, B. L., & Olson, E. N. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.167 · Cited by 1,037 · see citing works
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Tatham, M. H., Geoffroy, M., Shen, L., Plechanovová, A., Hattersley, N., Jaffray, E., Palvimo, J. J., & Hay, R. T. (2008) · Nature Cell Biology · doi:10.1038/ncb1716 · Cited by 837 · see citing works
Reid, G., Hübner, M. R., Métivier, R., Brand, H., Denger, S., Manu, D., Beaudouin, J., Ellenberg, J., & Gannon, F. (2003) · Molecules and Cells · doi:10.1016/s1097-2765(03)00090-x · Cited by 787 · see citing works
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Zhang, X., Yan, X.-J., Zhou, Z., Yang, F., Wu, Z., Sun, H., Liang, W., Song, A., Lallemand-Breitenbach, V., Jeanne, M., et al. (2010) · Science · doi:10.1126/science.1183424 · Cited by 785 · see citing works
Ubiquitin-Binding Proteins: Decoders of Ubiquitin-Mediated Cellular Functions
Husnjak, K., & Đikić, I. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051810-094654 · Cited by 755 · see citing works
Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Lallemand-Breitenbach, V., Jeanne, M., Benhenda, S., Nasr, R., Lei, M., Pérès, L., Zhou, J., Zhu, J., Raught, B., & de Thé, H. (2008) · Nature Cell Biology · doi:10.1038/ncb1717 · Cited by 726 · see citing works
A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo
Yuzwa, S. A., Macauley, M. S., Heinonen, J. E., Shan, X., Dennis, R. J., He, Y., Whitworth, G. E., Stubbs, K. A., McEachern, E. J., Davies, G. J., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.96 · Cited by 717 · see citing works
The CREB Coactivator TORC2 Functions as a Calcium- and cAMP-Sensitive Coincidence Detector
Screaton, R. A., Conkright, M. D., Katoh, Y., Best, J. L., Canettieri, G., Jeffries, S., Guzmán, E., Niessen, S., Yates, J. R., Takemori, H., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.015 · Cited by 640 · see citing works
SUMO‐1 modification activates the transcriptional response of p53
Rodríguez, M. S., Desterro, J. M. P., Laı́n, S., Midgley, C., Lane, D. P., & Hay, R. T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6455 · Cited by 639 · see citing works
Shangary, S., & Wang, S. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094723 · Cited by 623 · see citing works
Integrated proteomic analysis of post-translational modifications by serial enrichment
Mertins, P., Qiao, J., Patel, J., Udeshi, N. D., Clauser, K. R., Mani, D. R., Burgess, M. W., Gillette, M. A., Jaffe, J. D., & Carr, S. A. (2013) · Nature Methods · doi:10.1038/nmeth.2518 · Cited by 619 · see citing works
Nakae, J., Biggs, W., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 612 · see citing works
Global analysis of phosphorylation and ubiquitylation cross-talk in protein degradation
Swaney, D. L., Beltrão, P., Starita, L. M., Guo, A., Rush, A. J., Fields, S., Krogan, N. J., & Villén, J. (2013) · Nature Methods · doi:10.1038/nmeth.2519 · Cited by 601 · see citing works
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
Choi, J. H., Banks, A. S., Kamenecka, T. M., Busby, S. A., Chalmers, M. J., Kumar, N., Kuruvilla, D. S., Shin, Y., He, Y., Bruning, J. B., et al. (2011) · Nature · doi:10.1038/nature10383 · Cited by 541 · see citing works
Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation
Matsuzaki, H., Daitoku, H., Hatta, M., Tanaka, K., & Fukamizu, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934283100 · Cited by 534 · see citing works
Okamura, H., Aramburu, J. F., García‐Rodríguez, C., Viola, J. P. B., Raghavan, A., Tahiliani, M., Zhang, X., Qin, J., Hogan, P. G., & Rao, A. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00053-8 · Cited by 481 · see citing works
FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP
van der Horst, A., de Vries-Smits, A. M. M., Brenkman, A. B., van Triest, M. H., van den Broek, N. J. F., Colland, F., Maurice, M. M., & Burgering, B. M. T. (2006) · Nature Cell Biology · doi:10.1038/ncb1469 · Cited by 479 · see citing works
Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation
Matsuzaki, H., Daitoku, H., Hatta, M., Aoyama, H., Yoshimochi, K., & Fukamizu, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502738102 · Cited by 479 · see citing works
Nakae, J., Park, B., & Accili, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.15982 · Cited by 474 · see citing works
A Calcium-Regulated MEF2 Sumoylation Switch Controls Postsynaptic Differentiation
Shalizi, A., Gaudilliere, B. L., Yuan, Z., Stegmüller, J., Shirogane, T., Ge, Q., Tan, Y. L., Schulman, B. A., Harper, J. W., & Bonni, A. (2006) · Science · doi:10.1126/science.1122513 · Cited by 456 · see citing works
Trinidad, J. C., Barkan, D. T., Gulledge, B. F., Thalhammer, A., Šali, A., Schoepfer, R., & Burlingame, A. L. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o112.018366 · Cited by 426 · see citing works
Systematic Functional Prioritization of Protein Posttranslational Modifications
Beltrão, P., Albanèse, V., Kenner, L., Swaney, D. L., Burlingame, A. L., Villén, J., Lim, W. A., Fraser, J. S., Frydman, J., & Krogan, N. J. (2012) · Cell · doi:10.1016/j.cell.2012.05.036 · Cited by 425 · see citing works
linking metabolism to epigenetics through O-GlcNAcylation
Hanover, J. A., Krause, M. W., & Love, D. C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3334 · Cited by 414 · see citing works
Emerging Roles of Ubiquitin in Transcription Regulation
Conaway, R. C., Brower, C. S., & Conaway, J. W. (2002) · Science · doi:10.1126/science.1067466 · Cited by 391 · see citing works
ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity
Colicelli, J. (2010) · Science Signaling · doi:10.1126/scisignal.3139re6 · Cited by 365 · see citing works
Regulation of transcription factor function by phosphorylation
Whitmarsh, A. J., & Davis, R. J. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000757 · Cited by 345 · see citing works
Multisite phosphorylation provides sophisticated regulation of transcription factors
Holmberg, C. I., Tran, S. E. F., Eriksson, J., & Sistonen, L. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02207-7 · Cited by 323 · see citing works
Ubiquitin and Proteasomes in Transcription
Geng, F.-Q., Wenzel, S., & Tansey, W. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052110-120012 · Cited by 302 · see citing works
Phosphorylation of Serine 256 Suppresses Transactivation by FKHR (FOXO1) by Multiple Mechanisms
Zhang, X., Gan, L., Pan, H., Guo, S., He, X., Olson, S. T., Mesecar, A. D., Adam, S. A., & Unterman, T. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208063200 · Cited by 294 · see citing works
SUMO: A Multifaceted Modifier of Chromatin Structure and Function
Cubeñas-Potts, C., & Matunis, M. J. (2013) · Developmental Cell · doi:10.1016/j.devcel.2012.11.020 · Cited by 281 · see citing works
Regulation of MEF2 by Histone Deacetylase 4- and SIRT1 Deacetylase-Mediated Lysine Modifications
Zhao, X., Sternsdorf, T., Bolger, T. A., Evans, R. M., & Yao, T.-P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8456-8464.2005 · Cited by 264 · see citing works
Zhao, X., Gan, L., Pan, H., et al. (2004) · Biochemical Journal · doi:10.1042/bj20031450 · Cited by 244 · see citing works
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
Rena, G., Woods, Y. L., Prescott, A. R., Peggie, M., Unterman, T. G., Williams, M. R., & Cohen, P. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2263 · Cited by 241 · see citing works
A SIM-ultaneous role for SUMO and ubiquitin
Perry, J. J. P., Tainer, J. A., & Boddy, M. N. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.02.001 · Cited by 224 · see citing works
Cracking the O-GlcNAc code in metabolism
Ruan, H., Singh, J. P., Li, M., Wu, J., & Yang, X. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.02.002 · Cited by 224 · see citing works
Cellular functions of the DUBs
Clague, M. J., Coulson, J. M., & Urbé, S. (2012) · Journal of Cell Science · doi:10.1242/jcs.090985 · Cited by 221 · see citing works
Kawabe, Y.-I., Wang, Y. X., McKinnell, I. W., Bedford, M. T., & Rudnicki, M. A. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.07.001 · Cited by 220 · see citing works
Acute promyelocytic leukemia, arsenic, and PML bodies
de Thé, H., Bras, M. L., & Lallemand-Breitenbach, V. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201112044 · Cited by 212 · see citing works
Tan, Y., Yu, R., & Pezzuto, J. M. (2003) · PubMed · Cited by 188 · see citing works
Regulation of CK2 by phosphorylation and O-GlcNAcylation revealed by semisynthesis
Tarrant, M. K., Rho, H., Xie, Z., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.771 · Cited by 187 · see citing works
Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activityPreprint
Zhao, X., Jankovic, V. S., Gural, A., Huang, G., Pardanani, A. D., Menéndez, S., Zhang, J., Dunne, R. F., Xiao, A., Erdjument‐Bromage, H., et al. (2008) · Genes & Development · doi:10.1101/gad.1632608 · Cited by 184 · see citing works
The Fast-Growing Business of SUMO Chains
Ulrich, H. D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.10.010 · Cited by 180 · see citing works
Control of MEF2 Transcriptional Activity by Coordinated Phosphorylation and Sumoylation
Grégoire, S., Tremblay, A., Xiao, L., Yang, Q., Ma, K., Nie, J., Mao, Z., Wu, Z., Giguère, V., & Yang, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509471200 · Cited by 171 · see citing works
Ma, K., Chan, J. K. L., Zhu, G., & Wu, Z. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3575-3582.2005 · Cited by 165 · see citing works
Ouyang, J., Shi, Y. G., Valín, Á., Xuan, Y., & Gill, G. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.03.013 · Cited by 161 · see citing works
Stankovic‐Valentin, N., Deltour, S., Seeler, J.-S., Pinte, S., Vergoten, G., Guérardel, C., Dejean, A., & Leprince, D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01098-06 · Cited by 153 · see citing works
Regulation of gene expression by transcription factor acetylation
Bannister, A. J., & Miska, E. A. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000758 · Cited by 150 · see citing works
Luis, N. M., Morey, L., Mejetta, S., Pascual, G., Janich, P., Kuebler, B., Roma, G., Nascimento, E., Frye, M., Di Croce, L., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.07.013 · Cited by 142 · see citing works
Tunable Signal Processing Through Modular Control of Transcription Factor Translocation
Hao, N., Budnik, B., Gunawardena, J., & O’Shea, E. K. (2013) · Science · doi:10.1126/science.1227299 · Cited by 141 · see citing works
Farrell, A. S., Pelz, C., Wang, X., Daniel, C. J., Wang, Z., Su, Y., Janghorban, M., Zhang, X., Morgan, C. W., Impey, S., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01455-12 · Cited by 140 · see citing works
Mínguez, P., Letunić, I., Parca, L., & Bork, P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1230 · Cited by 138 · see citing works
A Recurrent Phospho-Sumoyl Switch in Transcriptional Repression and Beyond
Yang, X., & Grégoire, S. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.08.009 · Cited by 117 · see citing works
Differential Effects of an O-GlcNAcase Inhibitor on Tau Phosphorylation
Yu, Y., Zhang, L., Li, X., Run, X., Liang, Z., Li, Y., Liu, Y., Lee, M. H., Grundke, I., Iqbal, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035277 · Cited by 113 · see citing works
Arnold, H. K., & Sears, R. C. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9128-9 · Cited by 111 · see citing works
Judge, S. M., Sandesara, P. B., Reed, S. A., & Judge, A. R. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00255.2010 · Cited by 108 · see citing works
Ikaros SUMOylation: Switching Out of Repression
Arco, P. G., Koipally, J., & Georgopoulos, K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2688-2697.2005 · Cited by 106 · see citing works
Pin1 inhibitors: Pitfalls, progress and cellular pharmacology
Moore, J. D., & Potter, A. J. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.088 · Cited by 105 · see citing works
Structural basis for CARM1 inhibition by indole and pyrazole inhibitors
Sack, J. S., Thieffine, S., Bandiera, T., Fasolini, M., Duke, G. J., Jayaraman, L., Kish, K., Klei, H. E., Purandare, A. V., Rosettani, P., et al. (2011) · Biochemical Journal · doi:10.1042/bj20102161 · Cited by 105 · see citing works
Kowenz‐Leutz, E., Pleß, O., Dittmar, G. A. G., Knoblich, M., & Leutz, A. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.3 · Cited by 103 · see citing works
Bcl11b represses a mature T‐cell gene expression program in immature CD4+CD8+ thymocytes
Kastner, P., Chan, S. H., Vogel, W., Zhang, L., Topark‐Ngarm, A., Golonzhka, O., Jost, B., Gras, S. L., Gross, M. K., & Leid, M. E. (2010) · European Journal of Immunology · doi:10.1002/eji.200940258 · Cited by 98 · see citing works
Self-citationDifferential effects of garcinol and curcumin on histone and p53 modifications in tumour cells
Collins, H. M., Abdelghany, M. K., Messmer, M., Yue, B., Deeves, S. E., Kindle, K. B., Mantelingu, K., Aslam, A., Winkler, G. S., Kundu, T. K., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-37 · Cited by 96 · see citing works
Frank, C. L., Ge, X., Xie, Z., Zhou, Y., & Tsai, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.140699 · Cited by 93 · see citing works
Phosphatases in SMAD regulation
Bruce, D. L., & Sapkota, G. P. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.001 · Cited by 86 · see citing works
Yan, Q., Gong, L., Deng, M., Zhang, L., Sun, S., Liu, J., Ma, H., Yuan, D., Chen, P.-C., Hu, X., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007866107 · Cited by 83 · see citing works
Myocyte Enhancer Factor-2 Transcription Factors in Neuronal Differentiation and Survival
Heidenreich, K. A., & Linseman, D. A. (2004) · Molecular Neurobiology · doi:10.1385/mn:29:2:155 · Cited by 82 · see citing works
Rajbhandari, P., Finn, G., Solodin, N. M., Singarapu, K. K., Sahu, S. C., Markley, J. L., Kadunc, K., Miner, S. J., Kariagina, A., Haslam, S. Z., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06073-11 · Cited by 77 · see citing works
SUMOylation enhances DNA methyltransferase 1 activity
Lee, B., & Muller, M. T. (2009) · Biochemical Journal · doi:10.1042/bj20090142 · Cited by 76 · see citing works
Hsu, T., Wang, M.-C., Chen, S.-Y., et al. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.078485 · Cited by 73 · see citing works
Zhang, L., Vogel, W., Liu, X., Topark‐Ngarm, A., Arbogast, B. L., Maier, C. S., Filtz, T. M., & Leid, M. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.344176 · Cited by 70 · see citing works
Self-citationSUMOhydro: A Novel Method for the Prediction of Sumoylation Sites Based on Hydrophobic Properties
Chen, Y., Chen, Z., Gong, Y.-A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039195 · Cited by 69 · see citing works
Rajbhandari, P., Schalper, K. A., Solodin, N. M., Ellison-Zelski, S. J., Lu, K. P., Rimm, D. L., & Alarid, E. T. (2013) · Oncogene · doi:10.1038/onc.2013.78 · Cited by 69 · see citing works
Lysine methylation of promoter-bound transcription factors and relevance to cancer
Stark, G. R., Wang, Y., & Lu, T. (2010) · Cell Research · doi:10.1038/cr.2010.174 · Cited by 68 · see citing works
Huang, H., Woo, A. J., Waldon, Z., Schindler, Y. L., Moran, T. B., Zhu, H. H., Feng, G., Steen, H., & Cantor, A. B. (2012) · Genes & Development · doi:10.1101/gad.192054.112 · Cited by 67 · see citing works
Kanwal, S., Fardini, Y., Pagésy, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069150 · Cited by 62 · see citing works
Shen, T., Zong, C. C., Hamelberg, D., McCammon, J. A., & Wolynes, P. G. (2005) · The FASEB Journal · doi:10.1096/fj.04-3590hyp · Cited by 49 · see citing works
Rnf165/Ark2C Enhances BMP-Smad Signaling to Mediate Motor Axon Extension
Kelly, C. E., Thymiakou, E., Dixon, J. E., Tanaka, S., Godwin, J., & Episkopou, V. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001538 · Cited by 44 · see citing works
Defining an Embedded Code for Protein Ubiquitination
Jadhav, T., & Wooten, M. W. (2009) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000091 · Cited by 44 · see citing works
Lobo, V. J. S.-A., Doni, M., Verrecchia, A., Sanulli, S., Fagà, G., Piontini, A., Bianchi, M., Conacci‐Sorrell, M., Mazzarol, G., Peg, V., et al. (2013) · Oncogene · doi:10.1038/onc.2012.621 · Cited by 28 · see citing works
Selective Inhibition of CBP/p300 HAT
Sarli, V., & Giannis, A. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.06.001 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works
Jackson, C. A., Castro, D. M., Saldi, G.-A., Bonneau, R., & Gresham, D. (2020) · eLife · doi:10.7554/elife.51254 · Cited by 174 · see citing works
Targeting post-translational modification of transcription factors as cancer therapy
Qian, M., Yan, F., Yuan, T., Yang, B., He, Q., & Zhu, H. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.06.005 · Cited by 47 · see citing works
Casillas, A. L., Chauhan, S. S., Toth, R. K., Sainz, A. G., Clements, A. N., Jensen, C. C., Langlais, P. R., Miranti, C. K., Cress, A. E., & Warfel, N. A. (2021) · Oncogene · doi:10.1038/s41388-021-01915-1 · Cited by 44 · see citing works
Estimating the Distribution of Protein Post-Translational Modification States by Mass Spectrometry
Compton, P. D., Kelleher, N. L., & Gunawardena, J. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00150 · Cited by 30 · see citing works
- Authors
- Filtz, T. M., Vogel, W. K., & Leid, M.
- Affiliations
- Oregon State University (US)
- Corresponding author
- Filtz, Theresa M.
- Leid, Mark
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 35
- Issue
- 2
- Pages
- 76-85
- ISSN
- 0165-6147 (ISSN-L)
- PMC
- PMC3954851
- OpenAlex
- W1978279515
- Cited by
- 242
- References
- 88
- Citations by year
- 2026: 24 · 2025: 15 · 2024: 20 · 2023: 27 · 2022: 24 · 2021: 24 · 2020: 17 · 2019: 27 · 2018: 20 · 2017: 12 · 2016: 14 · 2015: 12 · 2014: 6
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Trends in Pharmacological Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (GM096243, R15GM096243)
- National Institute of Dental and Craniofacial Research (R15DE021879, DE021879)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- transcription factors, post-translational modification, epigenetic regulation, gene expression regulation, protein stability, subcellular localization, protein-protein interaction, DNA binding, signal transduction, therapeutic target
- MeSH terms
- Animals, Humans, Protein Processing, Post-Translational, Proteins, Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review